BlackRock’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,500,000
| Closed | -$15.4M | – | 5507 |
|
|
2023
Q2 | $15.4M | Hold |
1,500,000
| – | – | ﹤0.01% | 3125 |
|
|
2023
Q1 | $15.2M | Hold |
1,500,000
| – | – | ﹤0.01% | 3040 |
|
|
2022
Q4 | $14.9M | Sell |
1,500,000
-530
| -0% | -$5.25K | ﹤0.01% | 3127 |
|
|
2022
Q3 | $14.6M | Sell |
1,500,530
-530
| -0% | -$5.16K | ﹤0.01% | 3156 |
|
|
2022
Q2 | $14.5M | Hold |
1,501,060
| – | – | ﹤0.01% | 3210 |
|
|
2022
Q1 | $14.6M | Hold |
1,501,060
| – | – | ﹤0.01% | 3295 |
|
|
2021
Q4 | $14.7M | Buy |
1,501,060
+1,060
| +0.1% | +$10.4K | ﹤0.01% | 3389 |
|
|
2021
Q3 | $14.7M | Buy |
+1,500,000
| New | +$14.7M | ﹤0.01% | 3426 |
|